Morita M, Aoki M, Abe K, Hasegawa T, Sakuma R, Onodera Y, Ichikawa N, Nishizawa M, Itoyama Y
Department of Neurology, Tohoku University School of Medicine, Japan.
Neurosci Lett. 1996 Feb 23;205(2):79-82. doi: 10.1016/0304-3940(96)12378-8.
We have identified a novel two-base mutation in exon 1 of the Cu/Zn superoxide dismutase (SOD1) gene (TGC to TTT), which resulted in Cys6 to Phe substitution in a Japanese family with amyotrophic lateral sclerosis (ALS). This is the first case of familial ALS-associated two-base change of the SOD1 gene. Similar to several mutations in exon 1 of the SOD1 gene such as Ala4 to Val, Ala4 to Thr and Val14 to Met, affected members of the present family showed a rapid progression of motor dysfunction. Although Ala4, Cys6 and Val7 reside in the middle of the first beta-strand of the SOD1, a family with a mutation of Val7 to Glu associates with slow progression of the disease. These findings suggest that clinical courses are variable with each mutation, even in the same exon.
我们在一个患有肌萎缩侧索硬化症(ALS)的日裔家族中,鉴定出铜/锌超氧化物歧化酶(SOD1)基因外显子1中的一种新型双碱基突变(TGC突变为TTT),该突变导致了Cys6被Phe取代。这是首例与家族性ALS相关的SOD1基因双碱基改变。与SOD1基因外显子1中的几种突变,如Ala4突变为Val、Ala4突变为Thr以及Val14突变为Met类似,该家族的患病成员表现出运动功能障碍的快速进展。尽管Ala4、Cys6和Val7位于SOD1第一条β链的中部,但一个Val7突变为Glu的家族疾病进展缓慢。这些发现表明,即使在同一外显子中,每种突变的临床病程也各不相同。